Nitrogen-centered lactate oxidase nanozyme for tumor lactate modulation and microenvironment remodeling
S Zhao, H Li, R Liu, N Tao, L Deng, Q Xu… - Journal of the …, 2023 - ACS Publications
Designing nanozymes that match natural enzymes have always been an attractive and
challenging goal. In general, researchers mainly focus on the construction of metal centers …
challenging goal. In general, researchers mainly focus on the construction of metal centers …
[HTML][HTML] Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition
R He, J Zang, Y Zhao, Y Liu, S Ruan, X Zheng… - Journal of …, 2021 - Springer
Lactate plays a critical role in tumorigenesis, invasion and metastasis. Exhausting lactate in
tumors holds great promise for the reversal of the immunosuppressive tumor …
tumors holds great promise for the reversal of the immunosuppressive tumor …
[HTML][HTML] Lactate oxidase/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth
H Choi, M Yeo, Y Kang, HJ Kim, SG Park… - Journal of …, 2023 - Springer
The aggressive proliferation of tumor cells often requires increased glucose uptake and
excessive anaerobic glycolysis, leading to the massive production and secretion of lactate to …
excessive anaerobic glycolysis, leading to the massive production and secretion of lactate to …
O2-Supplying Nanozymes Alleviate Hypoxia and Deplete Lactate to Eliminate Tumors and Activate Antitumor Immunity
Direct hypoxia alleviation and lactate depletion in the tumor microenvironment (TME) are
promising for effective cancer therapy but still very challenging. To address this challenge …
promising for effective cancer therapy but still very challenging. To address this challenge …
Lactate Efflux Inhibition by Syrosingopine/LOD Co‐Loaded Nanozyme for Synergetic Self‐Replenishing Catalytic Cancer Therapy and Immune Microenvironment …
S Wu, L Xu, C He, P Wang, J Qin, F Guo… - Advanced …, 2023 - Wiley Online Library
An effective systemic mechanism regulates tumor development and progression; thus, a
rational design in a one‐stone‐two‐birds strategy is meant for cancer treatment. Herein, a …
rational design in a one‐stone‐two‐birds strategy is meant for cancer treatment. Herein, a …
Chiral carbon dots-enzyme nanoreactors with enhanced catalytic activity for cancer therapy
P Gao, S Chen, S Liu, H Liu, Z Xie… - ACS Applied Materials & …, 2021 - ACS Publications
As a class of functional proteins, enzymes possess inherent insignificant features, for
instance, mediocre stability and membrane impermeability and reduced enzymatic activity …
instance, mediocre stability and membrane impermeability and reduced enzymatic activity …
[HTML][HTML] In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy
K Fan, J Xi, L Fan, P Wang, C Zhu, Y Tang, X Xu… - Nature …, 2018 - nature.com
Nanomaterials with intrinsic enzyme-like activities (nanozymes), have been widely used as
artificial enzymes in biomedicine. However, how to control their in vivo performance in a …
artificial enzymes in biomedicine. However, how to control their in vivo performance in a …
Tumor‐targeted disruption of lactate transport with reactivity‐reversible nanocatalysts to amplify oxidative damage
X Wang, Y Zhao, L Shi, Y Hu, G Song, K Cai, M Li… - Small, 2021 - Wiley Online Library
Nanocatalytic tumor therapy is an emerging antitumor option that employs catalytically‐
active inorganic nanostructures to produce tumor‐damaging reactive oxygen species …
active inorganic nanostructures to produce tumor‐damaging reactive oxygen species …
Tumor‐microenvironment‐responsive cascade reactions by a cobalt‐single‐atom nanozyme for synergistic nanocatalytic chemotherapy
S Cai, J Liu, J Ding, Z Fu, H Li, Y Xiong… - Angewandte …, 2022 - Wiley Online Library
Nanocatalytic therapy, involving the nanozyme‐triggered production of reactive oxygen
species (ROS) in the tumor microenvironment (TME), has demonstrated potential in tumor …
species (ROS) in the tumor microenvironment (TME), has demonstrated potential in tumor …
Engineering lactate-modulating nanomedicines for cancer therapy
J Chen, Y Zhu, C Wu, J Shi - Chemical Society Reviews, 2023 - pubs.rsc.org
Lactate in tumors has long been considered “metabolic junk” derived from the glycolysis of
cancer cells and utilized only as a biomarker of malignancy, but is presently believed to be a …
cancer cells and utilized only as a biomarker of malignancy, but is presently believed to be a …